PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
04-Dec-2019 Chiesi outlines €350 million investment and announces the development of the first carbon minimal pressurised Metered Dose Inhaler (pMDI) for Asthma and COPD Chiesi Group
04-Dec-2019 Kancera reports in-depth analysis of the Phase Ib program with KAND567, showing the desired effect on the human immune system Kancera AB
04-Dec-2019 MaxCyte and KSQ Therapeutics Announce Development and Commercialization Agreement to Enable the Advancement of KSQ’s Adoptive Cell Therapy Programs MaxCyte, Inc.
04-Dec-2019 Aqilion strengthens its portfolio with two innovative pharmaceutical projects in the fields of inflammation and oncology AQILION AB
04-Dec-2019 MaxCyte and KSQ Therapeutics Announce Development and Commercialization Agreement to Enable the Advancement of KSQ’s Adoptive Cell Therapy Programs MaxCyte
03-Dec-2019 Owkin teams up with NVIDIA and King's College London to deliver AI to hospitals while protecting patient data with Federated Learning Owkin
03-Dec-2019 Tangerine Medical adopts MPEG-G data format for end-to-end genomic data processing GenomSys
03-Dec-2019 Cancer – New Inhibitor Effective Where Others Fail Karl Landsteiner University of Health Sciences
03-Dec-2019 Announces Distribution Agreement with Apex Ascension Healthcare plc
03-Dec-2019 ASLAN PHARMACEUTICALS ANNOUNCES PRICING OF $12.8 MILLION PUBLIC OFFERING OF AMERICAN DEPOSITARY SHARES ASLAN Pharmaceuticals
02-Dec-2019 Confo Therapeutics reports grant of two key patents for ConfoBodies™ Confo Therapeutics
02-Dec-2019 ASLAN PHARMACEUTICALS REPORTS POSITIVE PRELIMINARY DATA FROM PROOF-OF-CONCEPT STUDY FOR ASLAN004 TARGETING ATOPIC DERMATITIS ASLAN Pharmaceuticals
02-Dec-2019 Destiny Pharma to present at the Partnerships to Tackle the Global Challenge of AMR, UK-China AMR Workshop Destiny Pharma plc
02-Dec-2019 Cambridge Innovation Capital has attracted £1 billion of investment into Cambridge companies Cambridge Innovation Capital
02-Dec-2019 Lewis Cameron, Former Head of Global Clinical Development at Covance, Appointed as Chief Operating Officer Ergomed plc
02-Dec-2019 ABPI appoints Dr Richard Torbett as new Chief Executive The Association of the British Pharmaceutical Industry (ABPI)
02-Dec-2019 Elucid Health achieves 100% robustness in ongoing trials of their Pill Connect smart pill bottle that could help improve adherence to medications Elucid Health
02-Dec-2019 NICE EXPANDS RECOMMENDATION FOR LYNPARZATM (OLAPARIB) TABLETS FOR WOMEN WITH RELAPSED, BRCA-MUTATED, ADVANCED OVARIAN CANCER[I] AstraZeneca
02-Dec-2019 BioMed X Reaches Milestone in Respiratory Disease Research Collaboration with Boehringer Ingelheim BioMed X Innovation Center
02-Dec-2019 Akari Therapeutics Announces Pivotal Phase III Trial Design of Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA), Following FDA Meeting Akari Therapeutics